The Searle Company Limited (PSX:SEARL)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
83.76
-9.31 (-10.00%)
At close: Mar 2, 2026
1.10%
Market Cap 54.75B
Revenue (ttm) 33.26B
Net Income (ttm) 358.56M
Shares Out 588.22M
EPS (ttm) n/a
PE Ratio 152.68
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,061,524
Average Volume 3,502,686
Open 83.76
Previous Close 93.07
Day's Range 83.76 - 87.49
52-Week Range 52.75 - 137.44
Beta 0.52
RSI 23.57
Earnings Date Feb 26, 2026

About The Searle Company

The Searle Company Limited, together with its subsidiaries, manufactures and sells pharmaceutical and other consumer products in Pakistan, Sri Lanka, Myanmar, Cambodia, Vietnam, Iraq, Oman, Afghanistan, Tajikistan, Laos, Kenya, and internationally. The company offers pharmaceutical products, such as analgesics and muscle relaxants, anti-allergy and anti-tussive, anti-anemic, anti-chelating, anti-infective, anti-neoplastic, anti-thrombotic, cardiovascular, endocrinology and metabolism, gastrointestinal, gynecology, urology and sex hormones, hepa... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1965
Employees 3,799
Stock Exchange Pakistan Stock Exchange
Ticker Symbol SEARL
Full Company Profile

Financial Performance

In fiscal year 2025, The Searle Company's revenue was 28.60 billion, a decrease of -2.72% compared to the previous year's 29.40 billion. Losses were -1.40 billion, -41.15% less than in 2024.

Financial Statements

News

There is no news available yet.